US House Republican leader blasts PhRMA on healthcare reform deal
This article was originally published in Scrip
Executive Summary
US House Republican leader John Boehner of Ohio has penned a harsh letter to PhRMA president and CEO Billy Tauzin criticising the group's "short-sighted deal" with the White House for $80 billion in Medicare prescription drug savings over 10 years. The deal essentially endorses a federal takeover of healthcare and will not protect the interests of pharmaceutical companies or their employees from government intervention, Mr Boehner said.